KEY FEATURES
| Full Name | Extracellular Matrix Metalloproteinase Inducer |
|---|---|
| Synonym | EMMPRIN/CD147 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 62.5-4000pg/ml |
| Sensitivity | 31.25pg/ml |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human EMMPRIN/CD147 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human EMMPRIN/CD147. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human EMMPRIN/CD147 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human EMMPRIN/CD147, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human EMMPRIN/CD147. You can calculate the concentration of Human EMMPRIN/CD147 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human EMMPRIN/CD147 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/ml) | 202.26 | 614.3 | 1990.43 | 199.47 | 607.44 | 2084.25 |
| Standard deviation | 12.6 | 24.57 | 84.59 | 11.13 | 27.21 | 77.12 |
| CV(%) | 6.23 | 4 | 4.25 | 5.58 | 4.48 | 3.7 |
RECOVERY
The recovery of Human EMMPRIN/CD147 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-100 | 95 |
| EDTA plasma (n=8) | 97-107 | 102 |
| Cell culture media (n=8) | 85-96 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human EMMPRIN/CD147 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with BSG ELISA Kits
| SLC16A4 ELISA Kit | publications with BSG and SLC16A4 |
| MMP1 ELISA Kit | publications with BSG and MMP1 |
| SLC16A3 ELISA Kit | publications with BSG and SLC16A3 |
| CAV1 ELISA Kit | publications with BSG and CAV1 |
| AJAP1 ELISA Kit | publications with BSG and AJAP1 |
| SLC16A8 ELISA Kit | publications with BSG and SLC16A8 |
| PPIL2 ELISA Kit | publications with BSG and PPIL2 |
| SLC16A1 ELISA Kit | publications with BSG and SLC16A1 |
Pathways associated with BSG ELISA Kit
| Basigin Interactions Pathway | Basigin Interactions Pathway |
| Cell Surface Interactions At The Vascular Wall Pathway | Cell Surface Interactions At The Vascular Wall Pathway |
| Degradation Of The Extracellular Matrix Pathway | Degradation Of The Extracellular Matrix Pathway |
| Extracellular Matrix Organization Pathway | Extracellular Matrix Organization Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| Integrin Cell Surface Interactions Pathway | Integrin Cell Surface Interactions Pathway |
| Matrix Metalloproteinases Pathway | Matrix Metalloproteinases Pathway |
| Metabolism Pathway | Metabolism Pathway |
| Pyruvate Metabolism Pathway | Pyruvate Metabolism Pathway |
| Pyruvate Metabolism And Citric Acid (TCA) Cycle Pathway | Pyruvate Metabolism And Citric Acid (TCA) Cycle Pathway |
Diseases associated with BSG ELISA Kit
| Carcinoma | publications with BSG and Carcinoma |
| Neoplasm Metastasis | publications with BSG and Neoplasm Metastasis |
| Neoplasm Invasiveness | publications with BSG and Neoplasm Invasiveness |
| Adenocarcinoma | publications with BSG and Adenocarcinoma |
| Inflammation | publications with BSG and Inflammation |
| Breast Neoplasms | publications with BSG and Breast Neoplasms |
| Liver Diseases | publications with BSG and Liver Diseases |
| Carcinoma, Hepatocellular | publications with BSG and Carcinoma, Hepatocellular |
| Liver Neoplasms | publications with BSG and Liver Neoplasms |
| Necrosis | publications with BSG and Necrosis |
Organs/Tissues associated with BSG ELISA Kit
| Blood | publications with BSG and Blood |
| Brain | publications with BSG and Brain |
| Vascular | publications with BSG and Vascular |
| Nerve | publications with BSG and Nerve |
| Liver | publications with BSG and Liver |
| Muscle | publications with BSG and Muscle |
| Lung | publications with BSG and Lung |
| Eye | publications with BSG and Eye |
| Embryonic Tissue | publications with BSG and Embryonic Tissue |
| Bone | publications with BSG and Bone |